COMPENSATION ARRANGEMENTS WITH NAMED EXECUTIVE OFFICERS
EXHIBIT 10.17
COMPENSATION ARRANGEMENTS WITH NAMED EXECUTIVE OFFICERS
The following are the annual salaries of our named executive officers as of March 1, 2005.
| Name |
| Position |
| Salary | ||
| |
| |
| | ||
| Kenneth G. Chahine, J.D., Ph.D. |
| President, Chief Executive Officer and Director |
| $ | 376,550 | |
| Thomas J. Paulson |
| Vice President, Finance, Chief Financial Officer and Secretary |
| $ | 260,441 | |
| Glenn Pierce, Ph.D., M.D. |
| Vice President, Research and Clinical Development |
| $ | 242,179 | |
| Dawn McGuire, M.D. |
| Chief Medical Officer |
| $ | 243,950 | |
| Kirk Johnson, Ph.D. |
| Vice President, Preclinical Research |
| $ | 219,625 | |
In addition to these named executive officers, we have three other executive officers who receive base salaries in amount commensurate to their position and role with the Company.
Bonuses are paid to executive officers based on subjective determinations by the Compensation Committee of amounts warranted. There are no target bonus amounts set.
